Cargando…

Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending

IMPORTANCE: Delivering low-value care can lead to unnecessary follow-up services and associated costs, and such care cascades have not been well examined in common clinical scenarios. OBJECTIVE: To evaluate the utilization and costs of care cascades of prostate-specific antigen (PSA) tests for prost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, David D., Daly, Allan T., Koethe, Benjamin C., Fendrick, A. Mark, Ollendorf, Daniel A., Wong, John B., Neumann, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682424/ https://www.ncbi.nlm.nih.gov/pubmed/36413364 http://dx.doi.org/10.1001/jamanetworkopen.2022.43449

Ejemplares similares

Low-Value Prostate-Specific Antigen Screening in Older Males
por: Kalavacherla, Sandhya, et al.
Publicado: (2023)

Trends in Low-Value Health Service Use and Spending in the US Medicare Fee-for-Service Program, 2014-2018
por: Mafi, John N., et al.
Publicado: (2021)

Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk
por: Fisher, Deborah A., et al.
Publicado: (2021)

Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer–Specific Mortality
por: Burgess, Laura, et al.
Publicado: (2022)

Association of Participation in a Value-Based Insurance Design Program With Health Care Spending and Utilization
por: Zhang, Hui, et al.
Publicado: (2023)

Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China
por: Zhang, J., et al.
Publicado: (2016)

Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation
por: Lai, Sue-Min, et al.
Publicado: (2022)

Disparities in Health Care Spending and Utilization Among Black and White Medicaid Enrollees
por: Wallace, Jacob, et al.
Publicado: (2022)

Utilization, Steering, and Spending in Vertical Relationships Between Physicians and Health Systems
por: Sinaiko, Anna D., et al.
Publicado: (2023)

Prostate hyperplasia in St Mary's Hospital Lacor: utility of prostate specific antigen in screening for prostate malignancy
por: Okidi, Ronald, et al.
Publicado: (2020)

Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test
por: Abashidze, Nino, et al.
Publicado: (2021)

Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort
por: Bergengren, Oskar, et al.
Publicado: (2021)

Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results
por: Yun, Hyunkyung, et al.
Publicado: (2023)

Utilization and Spending With Preventive Drug Lists for Asthma Medications in High-Deductible Health Plans
por: Sinaiko, Anna D., et al.
Publicado: (2023)

Association of Skilled Nursing Facility Ownership by Health Care Networks With Utilization and Spending
por: Kalata, Stanley, et al.
Publicado: (2023)

The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer
por: Bai, Xiaojing, et al.
Publicado: (2020)

Assessment of Spending for Patients Initiating Dialysis Care
por: League, Riley J., et al.
Publicado: (2022)

Association of Private Equity Acquisition of Physician Practices With Changes in Health Care Spending and Utilization
por: Singh, Yashaswini, et al.
Publicado: (2022)

Health Care Utilization and Spending in Medicare Advantage vs Traditional Medicare: A Difference-in-Differences Analysis
por: Schwartz, Aaron L., et al.
Publicado: (2021)

The Impact of Global Budgets on Pharmaceutical Spending and Utilization: Early Experience From the Alternative Quality Contract
por: Afendulis, Christopher C., et al.
Publicado: (2014)

Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
por: Dusetzina, Stacie B., et al.
Publicado: (2021)

Assessment of Care Cascades Following Low-Value Prostate-Specific Antigen Testing Among Veterans Dually Enrolled in the US Veterans Health Administration and Medicare Systems
por: Pickering, Aimee N., et al.
Publicado: (2022)

Preferences for More or Less Health Care and Association With Health Literacy of Men Eligible for Prostate-Specific Antigen Screening in Australia
por: Pickles, Kristen, et al.
Publicado: (2021)

Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review
por: Vernooij, Robin W M, et al.
Publicado: (2018)

Patient Cost-Sharing and Utilization of Breast Cancer Diagnostic Imaging by Patients Undergoing Subsequent Testing After a Screening Mammogram
por: Hughes, Danny R., et al.
Publicado: (2023)

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
por: Heijnsdijk, E A M, et al.
Publicado: (2009)

The Importance of Prostate-Specific Membrane Antigen Expression in Carotid Body Paragangliomas
por: Yasan, Hasan, et al.
Publicado: (2021)

The Importance of Prostate-Specific Membrane Antigen Expression in Salivary Gland Tumors
por: Sivrice, Mehmet Emre, et al.
Publicado: (2022)

Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
por: Kovac, Evan, et al.
Publicado: (2020)

Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis
por: Qin, Xiaojian, et al.
Publicado: (2021)

Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer
por: Nyame, Yaw A, et al.
Publicado: (2020)

(177)Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior (223)Ra (RALU Study)
por: Rahbar, Kambiz, et al.
Publicado: (2023)

Advice About Screening for Prostate Cancer With Prostate-Specific Antigen
por: Jean-Pierre, Gannel
Publicado: (2017)

Reallocating Cervical Cancer Preventive Service Spending from Low- to High-Value Clinical Scenarios
por: Rockwell, Michelle S., et al.
Publicado: (2023)

Prostate-Specific Membrane Antigen Expression on PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study
por: Calderoni, Letizia, et al.
Publicado: (2023)

Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
por: Raju, Govinda Nanjaiah Laxmana, et al.
Publicado: (2022)

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
por: Tikkinen, Kari A O, et al.
Publicado: (2018)

Spending on and Use of Clinician-Administered Drugs in Medicare
por: Hyland, Megan F., et al.
Publicado: (2023)

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
por: Beckmann, Kerri, et al.
Publicado: (2019)

Risk of Short-Term Prostate-Specific Antigen Recurrence and Failure in Patients With Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Sayan, Mutlay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5doaojd8tlutmfuir26hhqg5da